The results are consistent with those reported earlier, showing that IL-22+CD4+T cells but not IL-22+CD8+T cells were significantly increased in patients with RA and SLE, and that their frequency correlated with disease activity. This evidence concerns the gene IL22 and systemic lupus erythematosus.